BAY-8400 is a potent, selective, and orally active DNA-dependent protein kinase (DNA-PK) inhibitor (IC50 = 81 nM) that demonstrates synergistic efficacy when combined with targeted alpha therapies. BAY-8400 is applicable for cancer research [1].
Molecular Weight:
393.39
Purity:
99.53%
Formula:
C21H17F2N5O
Target:
DNA-PK
T9498
* VAT and and shipping costs not included. Errors and price changes excepted
